This educational activity consists of recorded presentations from Advances in the Management of Oncology Patients held in Orlando,Florida on April 6-8, 2011.
CLL remains incurable, but major advances in the understanding and treatment of this disease have resulted in improved response rates, longer durations of response, and improved overall survival. Not all elderly patients can tolerate aggressive chemotherapy, so the challenge becomes identifying the optimal treatment regimen for that particular patient. As clinical trials are released, more treatment approaches will continue to evolve. This presentation will address the current advances being made in the treatment of geriatric oncology patients diagnosed with CLL, as well as future treatment planning needed to address our aging population.

Learning Objectives
At the end of this educational activity, participants should be able to

1. Discuss treatment options for CLL in the geriatric oncology patient.
2. Review the need for future treatment planning for our aging population.

    

Faculty
Philip C. Amrein, MD
Hematology/Oncology
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Disclosures
Please click here to view disclosures and activity planning information.

Method of Participation
There are no fees for participating in or receiving credit for this activity.
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
Participants will receive a certificate upon successful completion of the activity, which includes the following:

• Completing the entire activity
• Completing the Pre- and Post-Activity Assessments, Activity Evaluation, and Application for Certificate of Credit forms

You must be logged into your account to participate in this activity. Begin by clicking Take Course and viewing the CE Info; then follow the prompts at the bottom of the screen. At the end of the activity you will be able to view, save, or print your certificate of participation. The Area of Practice you indicated in your profile corresponds with your certificate type. A complete listing of all of your activities can be found in your profile.

Sponsored By
This activity is sponsored by OptumHealth Education.

Commercial Support
This activity is supported by Allos Therapeutics, Amgen, Eisai, Novartis Oncology, Shire, Cephalon Oncology, genzyme, Millennium, Novartis, sanofi aventis, National Marrow Donor Program, The Children's Hospital of Philadelphia, and Purdue.

Hardware/Software Requirements
To view this activity you will need Internet Explorer 7.0+ or Firefox 3.0+ with Windows Media Player 9+, RealPlayer 12+, or Adobe Flash Player 9+. Be sure to disable your pop-up blocking software.